About ANI Generics
ANI Generics is a Healthcare company based in Hyderabad (India) founded in 2014. ANI Generics delivers pharmaceutical formulation, logistics, and regulatory services. It operates on a B2B model. Its Indian entity Ani Generics Private Limited reported revenue of ₹27.8 Lakh. Its focus areas include Pharmaceuticals, Drug Development and Formulation and Logistics.
Company details
ANI Generics ani generics delivers pharmaceutical formulation, logistics, and regulatory services through providing healthcare solutions, producing pharmaceutical products, drug development, and formulation and logistics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Website anigenerics.com
- Legal Name Ani Generics Private Limited
- Date of Incorporation 16 Jan, 2014
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹27.8 Lakh
FY 2023 · -60% YoY
- Net Loss-₹1.4 Lakh
FY 2023 · -5% margin
- EBITDA₹3.8 Lakh
FY 2023 · 14% margin
Associated legal entities of ANI Generics
ANI Generics operates through Ani Generics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ani Generics Private Limited CIN U24232TG2014PTC092352 | Active | 16 Jan 2014 | Hyderabad, Telangana | ₹0.3 Cr | 3 | View details |
Board of directors of Ani Generics Private Limited (ANI Generics)
Ani Generics Private Limited is the primary company behind ANI Generics. The board of Ani Generics Private Limited currently have 3 directors; the longest-serving is Indrani Akuraju, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Indrani Akuraju DIN 06766130 | Director | 16 Jan 2014 | 12 yrs 9 mo | Ani Generics Private Limited |
| Bala Pasha Mohammed DIN 07250516 | Director | 03 Aug 2015 | 11 yrs 2 mo | Ani Generics Private Limited |
| Mohammed Hussain Nazir DIN 07540798 | Director | 11 Jun 2016 | 10 yrs 4 mo | Ani Generics Private Limited |
Financials of ANI Generics
Figures of Ani Generics Private Limited, the primary company behind ANI Generics, for FY 2023. Revenue was ₹27.8 Lakh (-60% year on year). Net loss was -₹1.4 Lakh (-5% margin). EBITDA was ₹3.8 Lakh (14% margin). Revenue has grown at a compounded annual rate of -20% over three years and -3% over five years.
- ₹27.8 LakhRevenue · FY 2023 · -60% YoY
- -₹1.4 LakhNet loss · -5% margin
- ₹3.8 LakhEBITDA · 14% margin
- ₹1 LakhPaid-up capital
- -20%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ani Generics Private Limited are on its company page.
Detailed financial statements for ANI Generics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ani Generics
Complete news archive for ANI Generics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ANI Generics
ANI Generics was founded in 2014.
ANI Generics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind ANI Generics, Ani Generics Private Limited, reported revenue of ₹27.8 Lakh for FY 2023, down 60% year on year.
ANI Generics ani generics delivers pharmaceutical formulation, logistics, and regulatory services through providing healthcare solutions, producing pharmaceutical products, drug development, and formulation and logistics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
ANI Generics operates through Ani Generics Private Limited.
The legal entities of ANI Generics currently have 3 directors, including Mohammed Hussain Nazir, Bala Pasha Mohammed, Indrani Akuraju.